Armistice Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Armistice Capital’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-164,000	Closed	-$558K	–	312
2024 Q3	$558K	Buy	164,000 +70,000	+74%	+$394K	0.01%	187
2024 Q2	$610K	Sell	94,000 -51,000	-35%	-$308K	0.01%	174
2024 Q1	$1.07M	Buy	+145,000	New	+$1.26M	0.01%	159
2023 Q4	–	Sell	-48,571	Closed	-$768K	–	364
2023 Q3	$768K	Buy	+48,571	New	+$2.47M	0.01%	152

Other funds holding VCNX

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Armistice Capital's VCNX Position: Q4 2024 in Review

Armistice Capital sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 164,000 shares — an estimated $558K sold.

Armistice Capital first reported a position in VCNX in Q3 2023 and held it in 4 quarters. The position peaked at $1.07M in Q1 2024. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

Armistice Capital reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Armistice Capital sold 164,000 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $558K.
Armistice Capital first reported a position in Vaccinex, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Armistice Capital's Vaccinex, Inc. Common Stock position peaked at $1.07M in Q1 2024.
1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.